A California woman may be the first person to be cured of HIV without a bone marrow transplant, according to a recent report in Nature. More than 60 other so-called elite controllers, who have unusually potent immune responses to HIV, were found to have their virus sequestered in parts of their genome where it is unable to replicate.
The unusual case involves Loreen Willenberg, who acquired HIV in 1992. Her immune system has maintained control of the virus for decades without the use of antiretroviral treatment, and researchers have been unable to find any intact virus in more than 1.5 billion of her cells. Elite controllers are thought to make up less than half a percent of all people living with HIV.
I believe Loreen might indeed meet anyones definition of a cure, study coauthor Steven Deeks, MD, of the University of California at San Francisco, told POZ. Despite heroic efforts, we just could not find any virus that is able to replicate. Her immune system seems completely normal. Even her HIV antibodies levels are low, which is unprecedented in an untreated person.
Although antiretroviral therapy can keep HIV replication suppressed, the virus inserts its genetic material into the chromosomes of human cells, making it very difficult to eradicate. HIV can lie dormant in a reservoir of resting immune cells indefinitely, but when antiretrovirals are stopped and the cells become activated, they can start churning out new virus.
Previously, only two people were known to have been cured of HIV: Timothy Ray Brown, formerly know as the Berlin Patient, and a man in London. Both received bone marrow stem cell transplants from a donor with a rare genetic mutation that makes cells resistant to HIV entry. But this procedure is far too dangerous for people who dont need it to treat advanced cancer.
The new research suggests that Willenberg and some five dozen other people with long-term untreated HIV have their virus hidden away in their cells genomes in such as way that the viral genetic blueprint (known as a provirus) cant be used to produce new viral particles that can go on to infect other cells.
Xu Yu, MD, of the Ragon Institute of Massachusetts General Hospital, MIT and Harvard analyzed integrated HIV in millions of cells from 64 elite controllers and 41 typical HIV-positive people on antiretroviral therapy recruited at Mass General and San Francisco General Hospital.
In both groups, about 20% were women, the average age was approximately 56, they had been living with HIV for an average of 17 years and had undetectable virus according to standard tests for nine years. Overall, the elite controllers had a higher average CD4 count (about 900 versus 70, respectively).
The researchers used next-generation gene sequencing to characterize the participants viral blueprints, including where they were inserted into human chromosomes. They found that the elite controllers had fewer integrated proviruses, but a larger proportion of them were intact, or potentially capable of replicating. The virus in these individuals was highly consistent, without the wide variety of mutations seen in most people with HIV.
Whats more, their proviruses were integrated at distinct sites in the human genome, farther away from elements that enable viral replication. Specifically, the integrated DNA was not located near sites that switch on transcription or close to accessible chromatin, which contains histone proteins that package long DNA strands into a more compact form. The DNA must then be unwound from these proteins before it can be used to produce new virus.
These data suggest that a distinct configuration of the proviral reservoir represents a structural correlate of natural viral control, and that the quality, rather than the quantity, of viral reservoirs can be an important distinguishing feature for a functional cure of HIV-1 infection, Yu and colleagues wrote.
In a commentary accompanying the report, Nicolas Chomont, PhD, of the University of Montreal, characterized the proviruses in these elite controllers as being in a state of deep sleep compared with latent virus in typical people with HIV. This has only become apparent now because researchers have more sophisticated tools to pinpoint the location of proviruses within the genome.
It is unclear why this block and lock phenomenon happens in only a small proportion of people with HIV. Its possible that the virus ends up sequestered in these locations by chance. But the researchers think its more likely that the integrated proviruses at these sites are evolutionarily selected over time as the ones in locations more conducive to viral replication are eliminated by the immune system.
In Willenbergs case, the research team analyzed more than 1.5billion of her peripheral blood immune cells, including samples from gut tissue, where the virus often hides. Theycould not find any intact proviruses that could be used to produce new HIV. Given her absence of intact proviruses, the researcherswere unable to determine whether she ever fit the pattern of having latent HIV locked away in inaccessible locations.
Another 11 people, dubbed exceptional controllers, only had detectableprovirusesatremote sites in the genome where it could not replicate.Since this study, the researchers have discovered a couple more elite controllers who may qualify as additional cures, according to the New York Times.
This raises the possibility that a sterilizing cure of HIVmeaning complete eradicationmay be feasible in rare instances, the study authors suggested. A similar but less complete process may be at play in the subset of about 10% of people with HIV who maintain viral suppression after stopping antiretroviral therapy but who still have detectable proviruses (known as post-treatment controllers).
This research was first presented at the International AIDS Society Conference on HIV Science last summer, where Willenberg was referred to as the San Francisco Patient. Willenberg later went public with her status, and she and Yu discussed the study findings during a webinar with HIV cure advocates last November.
I broke out in tears when saw Dr. Yus final slide, said Willenberg, who over the years has participated in more than a dozen studies. I can only hope and pray that with continued dedication we can figure out how I have dumped the virus into the DNA junkyard.
The question now is whether its possible to develop treatments that could enable the millions of typical people with progressive HIV to become elite controllers like Willenberg. Chomont suggested that immune-based therapiesincluding CAR-T cellsmight be able to shrink the viral reservoir until it consists only of deeply latent proviruses that are unable to replicate.
The key question is how did her immune system achieve this remarkable state, Deeks said. We do not know. We need to find more people who are exceptional controllers like Loreen and get to work on figuring out the mechanism.
In this video fromamfAR, the Foundation for AIDS Research,Loreen Willenbergtalks about living as an elite controller of HIV.
Click here to read the Nature article.Click here for more news about HIV cure research.
- Stem Cell Therapy Market by Treatment,Application,End Users and Geography Forecast To 2026 - Kewaskum Statesman News Journal - September 15th, 2020
- Cell Culture Market: Chemically Defined Mediums Adaptation to Boost Market Growth - BioSpace - September 15th, 2020
- Stem cells, like Rosh Hashanah, give the opportunity to be reborn - The Jerusalem Post - September 15th, 2020
- Cancer Stem Cells Market to witness astonishing growth by 2026 | AbbVie, The Merck KGaA Group, Bionomics, Lonza Group - The PRNews Pulse - September 15th, 2020
- LAVA Therapeutics, Amsterdam UMC and Monash University Announce Publication of a Novel Cancer Immunotherapy Approach in Nature Cancer - Business Wire - September 15th, 2020
- Stem Cell Therapy Market To 2026: Growth Analysis By Manufacturers, Regions, Types And Applications - Kewaskum Statesman News Journal - September 15th, 2020
- Phase 3 TOURMALINE-MM2 Study Fails to Meet Primary Endpoint in Treating Newly Diagnosed Multiple Myeloma - Curetoday.com - September 15th, 2020
- GlycoT Therapeutics Grants Sublicense of Glycoengineering Technology to Daiichi Sankyo - BioSpace - September 15th, 2020
- Animal Stem Cell Therapy Market 2020 | Global (North America, Europe, Middle East & Africa, Latin America and the Asia Pacific) Market Status and... - August 29th, 2020
- Fighting Disease with Developments to Stem Cell Research - News-Medical.net - August 29th, 2020
- NK Cell Therapy and Stem Cell Therapy Market 2020 Industry Growth, Size, Trends, Share, Opportunities and Forecast to 2026 - Red & Black Student... - August 29th, 2020
- Stem Cell Banking Market : Facts, Figures and Analytical Insights 2020 2029 - Scientect - August 29th, 2020
- Impact of Radiation Therapy on Survivors of Pediatric Abdominal and Pelvic Tumors - Cancer Network - August 29th, 2020
- Global Cell Isolation Technology Market 2020 Analysis, Types, Applications, Forecast and COVID-19 Impact Analysis 2025 - Scientect - August 29th, 2020
- Mike Tyson reveals all after doctors gave him blood injection that left him feeling weird during stem cell t - The Irish Sun - August 29th, 2020
- Sterile Filtration Market To Reach USD 8.48 Billion By 2027 | CAGR: 7.7% | Reports And Data - PRNewswire - August 29th, 2020
- The Science of Survival: Evolving Research in Advanced Non-Small Cell Lung Cancer - Reuters - August 25th, 2020
- Stem Cell Antibody Market Demand Analysis and Projected huge Growth by 2025 - Scientect - August 25th, 2020
- Expression Therapeutics Announces Success in Developing a Stem Cell Lentiviral Gene Therapy for Hemophagocytic Lymphohistiocytosis (HLH) - PRNewswire - August 25th, 2020
- Global Cancer Stem Cell Market 2020 Top Industry Players Thermo Fisher Scientific, Inc., AbbVie, Inc., Merck KGaA, Bionomics, Lonza, Stemline... - August 25th, 2020
- Impact of COVID-19 on Stem Cell Therapy Market Global Industry Outlook, Share, Growth Analysis, Trends and top manufacture like Cellular Dynamics... - August 25th, 2020
- Global Cord Blood Corporation Reports Financial Results for the First Quarter of Fiscal 2021 - The Baytown Sun - August 25th, 2020
- Global Stem Cell Therapies Market on a Steady Growth Trail; Future Market Insights Provides Projections in Light of COVID-19 Pandemic in its New... - August 25th, 2020
- Longevity And Anti-Senescence Therapy Market Latest Advancements And Industry Outlook 2018 To 2023 - The News Brok - August 25th, 2020
- Potential Impact of COVID-19 on Cancer Stem Cells Market: What to Expect from Industry in 2020? - Scientect - August 25th, 2020
- North America ultra-low temperature freezer market is anticipated to reach US$ 313.19 million in 2027 from US$ 220.25 million in 2019 - GlobeNewswire - August 25th, 2020
- Adipose Tissue-derived Stem Cell Therapy Market Share Analysis, Application, Strategies of Key Players & Forecast to 2025 - Scientect - August 22nd, 2020
- Global Covid-19 impact on Stem Cell Banking Market Trends, Analysis by Application and Region by 2025| CCBC,CBR,ViaCord,Esperite - Scientect - August 22nd, 2020
- Creative Medical Technology Holdings Identifies Novel Mechanism of Action of AmnioStem Adult Stem Cell Product in Stroke - BioSpace - August 20th, 2020
- Stanford Children's Health Appoints New Chief of Pediatric Hematology, Oncology, Stem Cell Transplantation, and Regenerative Medicine - PRNewswire - August 20th, 2020
- Researchers Get First-Ever Look at a Rare but Vital Stem Cell in Humans - Technology Networks - August 20th, 2020
- OU professor awarded $550,178 grant by National Science Foundation - College of Arts and Sciences - 2020 - News - OU Magazine - News at OU - August 20th, 2020
- Israelis and Emiratis to develop COVID-19 stem-cell therapy - Jewish News of Greater Phoenix - August 20th, 2020
- Global Nerve Repair and Regeneration Market 2020-2025: The Potential of Stem Cell Therapy in Nerve Repair and Regeneration Fuels Opportunity -... - August 20th, 2020
- Shielded Stem Cells Improve The Cells' Ability To Heal Heart Injuries - Interesting Engineering - August 20th, 2020
- Stem Cell Therapy Market: Beating Growth Expectations- MEDIPOST, BIOTIME, BrainStorm Cell Therapeutics, Caladrius, JCR Pharmaceuticals, AlloSource -... - August 20th, 2020
- Ivan Volschenk | The Voice of Business on 2020 Propositions - Santa Clarita Valley Signal - August 20th, 2020
- Stem Cell Characterization and Analysis Tool Market 2020: Potential Growth, Challenges, and Know the Companies List Could Potentially Benefit or Loose... - August 20th, 2020
- Global Stem Cell Cryopreservation Equipments Market Trends, Growth Insight, Leaders, Services and Forecast to 2025 | Chart, Worthington Industries,... - August 20th, 2020
- Researchers find method to regrow cartilage in the joints - Stanford Medical Center Report - August 19th, 2020
- Israel and UAE team up on stem cell therapy research for COVID-19 - UPI News - August 19th, 2020
- Latest News 2020: Stem Cell Cartilage Regeneration Market by Coronavirus-COVID19 Impact Analysis With Top Manufacturers Analysis | Top Players: Anika... - August 19th, 2020
- Global 3D Cell Culture Market Expected to Expand at a CAGR of 14.1% during 2018-2027 - The Daily Chronicle - August 19th, 2020
- Global Stem Cell Therapy for Diabetes and Related Conditions Market Research Report 2020 Obervational Studies with Top Manufacturers like Athersys,... - August 19th, 2020
- Stem Cell Market Emerging Trends, Strong Application Scope, Size, Status, Analysis and Forecast to 2026 - AlgosOnline - August 19th, 2020
- Global Stem Cell Therapy Market Growth, Size, Analysis, Outlook by 2020 - Trends, Opportunities and Forecast to 2025 - AlgosOnline - August 19th, 2020
- Cell Separation Technologies Market Research Report by Technology, by Application, by End User - Global Forecast to 2025 - Cumulative Impact of... - August 16th, 2020
- Comprehensive Report on Stem Cell Therapy Market 2020 Focusing on Growth, Demand & Scope by 2026| Osiris Therapeutics, NuVasive, Chiesi... - August 16th, 2020
- Amniotic Fluid Stem Cell Therapy Market Forecasted To Surpass The Value Of US$ XX Mn/Bn By 2018 2026 - Scientect - August 16th, 2020
- Researcher John Craig Venter Is Awarded the 2020 Edogawa-NICHE Prize for His Accomplishment in Human Genome Research - Business Wire - August 16th, 2020
- GMP Cell Banking Services Gain Momentum among Stem Cell Research Institutes Due to Cost-effectiveness and Quality They Offer - TMR Research Blog - August 14th, 2020
- AgeX Therapeutics Reports Second Quarter 2020 Financial Results and Provides Business Update - Business Wire - August 14th, 2020
- Stem Cell Media Market Summary, Trends, Sizing Analysis and Forecast To 2025 - Express Journal - August 14th, 2020
- Scientists hope to bring Malaysian rhinoceros back from extinction with stem cell technology - National Post - August 14th, 2020
- Global Totipotent Stem Cell Market Insights And Extensive Research (2020-2025) | Company A - Owned - August 14th, 2020
- Future of Cancer Stem Cell Reviewed in a New Study Owned - Owned - August 14th, 2020
- US FDA Advisory Committee Votes Nine to One in Favor of Remestemcel-L (Ryoncil) for Efficacy in Children With Steroid-Refractory Acute Graft Versus... - August 14th, 2020
- Global and United States Epithelial Stem Cells Market Size, Comprehensive Analysis, Development Strategy, Future Plans and Industry Growth with High... - August 14th, 2020
- Biological Safety Testing Market: Segment of Reagents and Kits to Witness Promising Growth Due to Introduction of Innovative Technologies - BioSpace - August 14th, 2020
- Cell Sorting Market Research Report by Technology, by Offering, by Application, by End User - Global Forecast to 2025 - Cumulative Impact of COVID-19... - August 14th, 2020
- California Propositions on the 2020 Ballot - Fullerton Observer - August 13th, 2020
- Experimental COVID treatment may have saved man's life - 10News - August 13th, 2020
- Opportunities in the Global Induced Pluripotent Stem Cell (iPS Cell) Industry - PRNewswire - August 13th, 2020
- Drug development for severe respiratory diseases supported with $3.9 million grant - Washington University School of Medicine in St. Louis - August 13th, 2020
- Jasper Therapeutics Strengthens Management Team with Appointment of Biopharma Industry Executive Kevin N. Heller, M.D., as Executive Vice President,... - August 13th, 2020
- Training neural circuits early in development improves response, study finds - University of Illinois News - August 13th, 2020
- Microcarrier Bioreactor Market Trends, Key Driven Factors, Segmentation And Forecast To 2020-2026 | Thermo Fisher Scientific, Danaher, BD - The Daily... - August 13th, 2020
- Cell Therapy Technologies Market Research Report by Product, by Process, by Cell Type, by End User - Global Forecast to 2025 - Cumulative Impact of... - August 13th, 2020
- Sapience Therapeutics Announces First Patient Dosed with ST101 in Phase 1/2 Study in Patients with Advanced Unresectable and Metastatic Solid Tumors -... - August 13th, 2020
- High-throughput 3D screening for differentiation of hPSC-derived cell therapy candidates - Science Advances - August 7th, 2020
- Study: Early training of cell development and network improves response - News-Medical.Net - August 7th, 2020
- US government considers ethics of aborted tissue research - Angelus News - August 7th, 2020
- BCLI: Phase 3 ALS Data Expected by the End of November 2020 - Zacks Small Cap Research - August 7th, 2020
- Stem Cell Media Market with Competitive Analysis, New Business Developments and Top Companies: Thermo Fisher, STEMCELL Technologies - Owned - August 7th, 2020
- In Depth Analysis and Survey of COVID-19 Pandemic Impact on Global Umbilical Cord Blood (UCB) Stem Cell Market Report PDF 2020 Key Players Advanced... - August 7th, 2020
- Plant Stem Cell Market 2020 Share Growing Rapidly With Latest Trends, Development, Revenue, Demand And Forecast To 2029 - Owned - August 7th, 2020
- New Research Sheds Light on the Temporary Loss of Smell Stemming from COVID-19 - BioSpace - August 7th, 2020
- Comprehensive Report on Stem Cell Equipment Market 2020 | Size, Growth, Demand, Opportunities & Forecast To 2026 | Chart, Worthington Industries,... - August 7th, 2020
- With over 280 therapies under evaluation, the stem cell therapy market is estimated to be worth USD 8.5 Billion by 2030, claims Roots Analysis -... - August 3rd, 2020
- Stem Cell-Derived Cells Market Forecasted To Surpass The Value Of US$ XX Mn/Bn By 2019 2029 - Bulletin Line - August 3rd, 2020